MOSHI has purchased a Sprinter-type van to service patients in rural areas who suffer from OUD/SUD. MOSHI has also worked to train providers to expand services in rural locations via in-person and virtual solutions.

MOSHI

Mobile Opioid Solutions for Healthcare Integration

what are we up to

Key Initiatives

Mobile Solutions for Rural Communities

Mobile units such as converted vans or buses are uniquely designed to provide services to hard-to-reach populations.

Evidenced-Based Treatment OUD

To help with recovery, we connect patients to other services such as housing/shelter, food, employment resources, counseling, mental health care, primary care, legal identification, and more.

Target Mobile Unit Populations

Lack of transportation, geographic isolation, residence in underserved areas, and difficulty leaving work, school, or home can benefit from mobile OUD solutions.

FDA Approved Medication for OUD (MOUD)

MOUD has shown to significantly improve physical and mental health, help relationships, reunite families, lower rates of criminal activity, and increase the likelihood of employment and stable housing.

U.S. Drug Overdose Deaths are a Critical Concern

A Growing Problem

Top 10 Causes

Leading Cause of Death
0 th

In 2022, U.S. overdose deaths reached the top 10 leading causes of death, surpassing diabetes, kidney disease, and liver disease.

Total Deaths

Deaths in 2022
K+

Drug overdose deaths in the U.S. have risen from under 20,000 deaths in 2000 to over 100,000 deaths in 2022. 

Overdose Death Rates

Death Rate Increase
%

From 2019 to 2020, the drug overdose death rate increased 31.0% from 21.6 to 28.3, which was the largest annual increase over the period 2002–2022

Barriers to Healthcare Access in Rural Communities

Workforce shortages, limited healthcare facilities, distance and transportation issues, health literacy, and some social/cultural factors in rural areas act as barriers to care.

What can you do?

Help us expand access to care for people who have Opioid Use Disorder in rural communities.

Contact us: JakeW@c-who.org

Grant Disclosure:

This presentation is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $3,000,000 with 100% percentage funded by HRSA/HHS and $0 amount and 0% percentage funded by non-government sources. The contents are those of the authors and do not necessarily represent the official views of, nor an endorsement, by HRSA/HHS, or the U.S. Government

Translate »